Guangdong Vtr Bio-Tech Co.Ltd(300381)
Annual report for 2021
2022033
April 2022
Section I important tips, contents and definitions
The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
Chen shaomei, the person in charge of the company, Li Zhu, the person in charge of accounting, and Pu Xichun, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
All directors have attended the meeting of the board of directors to consider this report.
During the reporting period, the company’s operating revenue decreased by 1.18% compared with the same period of last year, and the net profit attributable to shareholders of listed companies decreased by 173.53% compared with the same period of last year, mainly due to the provision of asset impairment loss including goodwill, the rise of raw material and energy prices, production restrictions caused by power failure and production restriction, etc. investors are reminded to pay attention to investment risks.
The risk of performance fluctuation caused by the sale of assets. In recent years, the market competition of the company’s biomedical business has intensified, and a strong capital investment is needed to maintain the competitive advantage. The investment in the field of industrial enzyme preparation, which is still in the blue ocean, is also increasing year by year. Therefore, based on the comprehensive consideration of business development and strategic layout, the company plans to sell the assets related to the biomedical business through this major asset restructuring. After the completion of this transaction, the listed company will reduce the operating burden, enrich the cash flow, speed up the company’s industrial upgrading and better protect the interests of investors. Although the strategic adjustment of the company is based on the long-term development of the company and is in line with the long-term interests of the company, it does not rule out the possibility that the company’s short-term performance may fluctuate due to the sale of the business, and remind investors to pay attention to the risk of performance fluctuation.
The profit distribution plan approved by the board of directors is as follows: by December 31, 2021
Based on the total share capital of 490067316 shares, the company will distribute a cash dividend of 1.00 yuan (tax included) to all shareholders for every 10 shares, give 0 bonus shares (tax included), and increase 0 shares for every 10 shares to all shareholders with capital reserve.
catalogue
Section I important tips, contents and definitions Section 2 company profile and main financial indicators Section III Management Discussion and Analysis Section IV corporate governance 42 Section V environmental and social responsibility 62 section VI important matters Section VII changes in shares and shareholders 89 Section VIII preferred shares Section 9 relevant information of bonds 96 section x financial reporting ninety-nine
Directory of documents for future reference
1、 Financial statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting and the person in charge of accounting institutions. 2、 The original of the audit report with the seal of the accounting firm and the signature and seal of the certified public accountant. 3、 The originals of all company documents and announcements publicly disclosed on the media designated by the CSRC during the reporting period. 4、 The original of the 2021 annual report signed by the legal representative of the company. 5、 Other documents for future reference. Location of the above documents for reference: Securities Department of the company
interpretation
Explanatory item refers to the explanatory content
Guangdong Vtr Bio-Tech Co.Ltd(300381) . Company refers to Guangdong Vtr Bio-Tech Co.Ltd(300381)
General meeting of shareholders refers to the general meeting of Guangdong Vtr Bio-Tech Co.Ltd(300381) shareholders
Board of directors refers to Guangdong Vtr Bio-Tech Co.Ltd(300381) board of directors
Board of supervisors refers to Guangdong Vtr Bio-Tech Co.Ltd(300381) board of supervisors
The reporting period refers to January December 2021
Xinhexin refers to Hunan xinhexin biomedical Co., Ltd., a holding subsidiary of the company
Lihua pharmaceutical refers to Henan Lihua Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company
Hongying biotechnology refers to Hunan Hongying Biotechnology Co., Ltd., a holding subsidiary of the company
Hunan Gree refers to Hunan Gree Biotechnology Co., Ltd., a wholly-owned subsidiary of the company
Hunan Kangjie refers to Hunan Kangjie Biotechnology Co., Ltd., a wholly-owned subsidiary of Hunan Gree
Keyixin refers to Hunan keyixin biomedical Co., Ltd., a wholly-owned subsidiary of the company
Shiwei technology refers to Changsha Shiwei Technology Co., Ltd., a holding subsidiary of the company
A kind of substance with enzyme characteristics extracted from biology, which is mainly used to catalyze various chemical reactions in the process of food processing and biological enzyme preparation, such as feed production. It is characterized by low dosage, high catalytic efficiency and strong specificity
Steroid hormone refers to the main body of steroid drugs. It is a kind of tetracyclic aliphatic compounds with cyclopentane phenanthrene mother nucleus, which is mainly divided into two categories: corticosteroids and sex hormones
API refers to active pharmaceutical ingredients (API), that is, active pharmaceutical ingredients, substances with pharmacological activity that can be used in the production of pharmaceutical preparations
Intermediate refers to a kind of material produced in the process steps of API, which must undergo further molecular change or refining to become API
Macleaya refers to a perennial erect herb in the Papaveraceae, with lignified base and milky yellow pulp.
Hollow, with many branches in the upper part. The leaves are often light red; The petiole has a shallow groove
Antibiotics refer to a class of secondary metabolites produced by microorganisms or higher animals and plants in the process of life, which have resistance to pathogens or other activities, and can interfere with the development function of other living cells
Restriction and prohibition of antibiotics refer to the restriction and prohibition of the use of antibiotics
Alternative antibiotics
Section II Company Profile and main financial indicators
1、 Company information
Stock abbreviation Guangdong Vtr Bio-Tech Co.Ltd(300381) stock code Guangdong Vtr Bio-Tech Co.Ltd(300381)
Chinese name of the company Guangdong Vtr Bio-Tech Co.Ltd(300381)
Chinese abbreviation of the company Guangdong Vtr Bio-Tech Co.Ltd(300381)
Foreign name of the company (if any) Guangdong VTR bio-tech Co., Ltd
Abbreviation of the company’s foreign name (if any) VTR
Legal representative of the company: Chen shaomei
Registered address: No. 8, Pingbei 1st Road, Nanping high tech Industrial Zone, Zhuhai, Guangdong
Postal code of registered address: 519060
The historical change of the company’s registered address is not applicable
Office address: No. 8, Pingbei 1st Road, Nanping high tech Industrial Zone, Zhuhai, Guangdong
Postal code of office address: 519060
Company Internet website http://www.yiduoli.com.
E-mail [email protected].
2、 Contact person and contact information
Secretary of the board of directors and securities affairs representative
Name: Zhou Derong, Zhu Shanmin
Contact address: No. 8, Pingbei 1st Road, Nanping high tech Industrial Zone, Zhuhai City, Guangdong Province
Tel: 075686768888828 075686768888829
Fax: 07568680252
E-mail [email protected]. [email protected].
3、 Information disclosure and preparation location
The website of the stock exchange where the company discloses the annual report Shenzhen Stock Exchange http://www.szse.cn.
Media name and website of the company’s annual report http://www.cn.info.com.cn.
The company’s annual report is prepared at the Securities Department of the company
4、 Other relevant information: accounting firm employed by the company
Name of accounting firm: Zhitong accounting firm (special general partnership)
Office address of the accounting firm: 5th floor, Saite square, No. 22, Jianguomenwai street, Chaoyang District, Beijing
Name of signature accountant: Fan Wenjing, Yang congyue
Recommendation agencies engaged by the company to perform continuous supervision duties during the reporting period √ applicable □ not applicable
Name and office address of the sponsor during the supervision period
Jianguomennei street, Dongcheng District, Beijing November 16, 2020 – December 12, 2022 Jiang Hongya and Wang gangyue, 16 / F, tower a, Minsheng financial center, No. 28, Minsheng Securities Co., Ltd
-18th floor
Financial consultant hired by the company to perform continuous supervision duties during the reporting period □ applicable √ not applicable v. whether the company needs to retroactively adjust or restate the accounting data of previous years in terms of main accounting data and financial indicators □ yes √ no
20212020 year-on-year increase or decrease 2019
Operating income (yuan): 189216033627191476445888 – 1.18% 204813340403
Net profit attributable to shareholders of listed companies
(yuan)
